Cochlear chases Chinese sales

ASX-listed firm hoping to cash in on ageing Chinese population: report.

The head of medical device maker Cochlear believes the firm’s next great growth phase will come through expansion in China as the world’s second largest economy boosts healthcare spending, The Australian reports.

Cochlear chief executive Chris Roberts said the ASX-listed firm was in a position to capitalise on expectations China will spend $1 trillion on healthcare over the next six years as its population ages.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles